Biphasic Insulin Aspart 30 FlexPen

biphasic insulin aspart 30 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Biphasic Insulin Aspart 30 FlexPen, covering 2017-01-06 to 2017-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen™ in Subjects With Type 2 Diabetes [Phase 4]